مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت

9 years, including blinded follow up on 8, 306 women with an intact uterus at randomization in the NSABP P 1 risk reduction trial, the incidence of both adenocarcinomas and rare uterine sarcomas was increased in women taking Tamofen tamoxifen citrate